(3-Bromo-2,2-dimethylpropoxy)(tert-butyl)diphenylsilane, 98%, 100mg

4-Amino-1-methanesulfonylpiperidine, 97.0%, 10g

NT1-014B, 50mg

2-Methyl-1-(2-nitrophenyl)-1H-imidazole, 97.0%, 5g

6-Fluoro-7-methyl-1H-indole, 98%, 500mg

2,4-dimethyl-2'-(3-pyrrolinomethyl) benzophenone, 97.0%, 1g

(2-Methyl-thiazol-4-yl)-acetic acid, 95.0%, 250mg

3-((tert-Butoxycarbonyl)amino)-2-(4-(((triisopropylsilyl)oxy)methyl)phenyl)propanoic acid, 98%, 100mg

2-[(4-methoxy-3-methylpyridin-2-yl)methanesulfinyl]-5-(1H-pyrrol-1-yl)-1H-1,3-benzodiazole, 97%, 100mg

ethyl 2-amino-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate monohydrochloride, 5mg

HPLC column NUCLEODUR® C18 Gravity 5 µm, 250 mm, 4 mm, 1 Piece(s)

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanesulfonamide, 98%, 1g

Methyl 1-methyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 98+%, 100mg